H
Holly A. Black
Researcher at University of Edinburgh
Publications - 12
Citations - 185
Holly A. Black is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Copy-number variation & Genetic epidemiology. The author has an hindex of 6, co-authored 11 publications receiving 123 citations. Previous affiliations of Holly A. Black include University of Nottingham & Western General Hospital.
Papers
More filters
Journal ArticleDOI
Targeted next-generation sequencing makes new molecular diagnoses and expands genotype–phenotype relationship in Ehlers–Danlos syndrome
Ruwan A. Weerakkody,Jana Vandrovcova,Christina Kanonidou,Christina Kanonidou,Christina Kanonidou,Michael Mueller,Piyush Gampawar,Piyush Gampawar,Yousef Ibrahim,Penny J. Norsworthy,Jennifer Biggs,Abdulshakur Abdullah,David Ross,Holly A. Black,David J. P. Ferguson,Nicholas J.W. Cheshire,Hanadi Kazkaz,Rodney Grahame,Neeti Ghali,Anthony Vandersteen,Anthony Vandersteen,F. Michael Pope,Timothy J. Aitman,Timothy J. Aitman +23 more
TL;DR: Unbiased NGS-based sequencing made new molecular diagnoses outside the expected EDS genotype–phenotype relationship and identified previously undetected clinically actionable variants in aortopathy susceptibility genes.
Journal ArticleDOI
Genetic epidemiology of motor neuron disease-associated variants in the Scottish population
Holly A. Black,Danielle Leighton,Elaine M. Cleary,Elaine M. Cleary,Elaine Rose,Laura Stephenson,Shuna Colville,David Ross,Jon Warner,Mary Porteous,George Gorrie,Robert Swingler,David Goldstein,Matthew B. Harms,Peter Connick,Suvankar Pal,Timothy J. Aitman,Siddharthan Chandran +17 more
TL;DR: This study provides an accurate description of the genetic epidemiology of MND in Scotland and provides support for the contribution of both TBK1 and NEK1 to MND susceptibility in the Scottish population.
Journal ArticleDOI
A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection.
Martin A M Reijns,Louise Thompson,Juan Carlos Acosta,Holly A. Black,Holly A. Black,Francisco J. Sanchez-Luque,Francisco J. Sanchez-Luque,Austin Diamond,David A. Parry,Alison Daniels,Marie O'Shea,Carolina Uggenti,Maria C. Sanchez,Alan O'Callaghan,Michelle L.L. McNab,Martyna Adamowicz,Elias T. Friman,Toby W. Hurd,Edward J. Jarman,Frederic Li Mow Chee,Jacqueline K. Rainger,Marion F Walker,Camilla Drake,Dasa Longman,Christine Mordstein,Christine Mordstein,Sophie J. Warlow,Stewart McKay,Louise Slater,Morad Ansari,Ian Tomlinson,David Moore,Nadine Wilkinson,Jill Shepherd,Kate Templeton,Ingolfur Johannessen,Christine Tait-Burkard,Jürgen Haas,Nick Gilbert,Ian R. Adams,Andrew P. Jackson +40 more
TL;DR: A multiplex assay using well-established SARS-CoV-2 targets alongside a human cellular control and a viral spike-in control, which monitor sample quality and nucleic acid extraction efficiency, and demonstrates the feasibility of establishing a robust RT-qPCR assay at approximately 10% of the cost of equivalent commercial assays, which could benefit low-resource environments and make high-volume testing affordable.
Journal ArticleDOI
Accurate measurement of gene copy number for human alpha-defensin DEFA1A3
Fayeza F. Khan,Danielle Carpenter,Laura M. Mitchell,Omniah Mansouri,Holly A. Black,Jess Tyson,John A.L. Armour +6 more
TL;DR: Interrogation of rs4300027 and associated SNPs in Genome-Wide Association Study SNP data provides no evidence that alpha-defensin copy number is a strong risk factor for phenotypes such as Crohn’s disease, type I diabetes, HIV progression and multiple sclerosis.
Posted ContentDOI
A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection
Martin A M Reijns,Louise Thompson,Juan Carlos Acosta,Holly A. Black,Holly A. Black,Francisco J. Sanchez-Luque,Francisco J. Sanchez-Luque,Austin Diamond,Alison Daniels,Marie O'Shea,Carolina Uggenti,Maria C. Sanchez,Michelle L.L. McNab,Martyna Adamowicz,Elias T. Friman,Toby W. Hurd,Edward J. Jarman,Frederic Li Mow Chee,Jacqueline K. Rainger,Marion F Walker,Camilla Drake,Dasa Longman,Christine Mordstein,Christine Mordstein,Sophie J. Warlow,Stewart McKay,Louise Slater,Morad Ansari,Ian Tomlinson,David Moore,Nadine Wilkinson,Jill Shepherd,Kate Templeton,Ingolfur Johannessen,Christine Tait-Burkard,Jürgen Haas,Nick Gilbert,Ian R. Adams,Andrew P. Jackson +38 more
TL;DR: A multiplex assay using well-established SARS-CoV-2 targets alongside internal controls that monitor sample quality and nucleic acid extraction efficiency is developed and established that this test performs as well as widely used commercial assays, but at substantially reduced cost.